Skip to content

Motivational and mindfulness intervention for young adult female marijuana users.

Marcel A De Dios, Debra S. Herman, Willoughby B. Britton, Claire E Hagerty, Bradley J Anderson, Michael D. Stein

Journal of Substance Abuse Treatment January 2012 DOI: 10.1016/j.jsat.2011.08.001 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial (pilot) Pilot study Peer reviewed
Sample size 34
Population Female marijuana users aged 18 to 29
Duration Two sessions; follow-up at 1, 2, and 3 months posttreatment
Topics Cannabis Meditation
Key findings Women who received two sessions of motivational interviewing plus mindfulness meditation reported using marijuana on 6.15, 7.81, and 6.83 fewer days at one, two, and three months, respectively, than assessment-only controls. The authors present these results as preliminary evidence of feasibility and effectiveness for this brief intervention.

Abstract

This pilot study tested the efficacy of a brief intervention using motivational interviewing (MI) plus mindfulness meditation (MM) to reduce marijuana use among young adult females. Thirty-four female marijuana users between the ages of 18 and 29 were randomized to either the intervention group (n = 22), consisting of two sessions of MI-MM, or an assessment-only control group (n = 12). The participants' marijuana use was assessed at baseline and at 1, 2, and 3 months posttreatment. Fixed-effects regression modeling was used to analyze treatment effects. Participants randomized to the intervention group were found to use marijuana on 6.15 (z = -2.42, p = .015), 7.81 (z = -2.78, p = .005), and 6.83 (z = -2.23, p = .026) fewer days at Months 1, 2, and 3, respectively, than controls. Findings from this pilot study provide preliminary evidence for the feasibility and effectiveness of a brief MI-MM for young adult female marijuana users.

Comparable studies

Other randomized controlled trials on cannabis, most cited first.

Study Year Design Participants
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment Healthy participants 2012 Randomized controlled trial n = 48
Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Healthy, English-native, right-handed men who had used cannabis 15 times or less in... 2009 Double-blind, randomized, placebo-controlled crossover trial n = 15
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers Healthy male subjects 2012 Randomized controlled trial n = 16
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol Healthy, native English-speaking, right-handed men of white race/ethnicity who had used... 2009 Randomized controlled trial n = 15
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition Healthy volunteers with a history of light cannabis use 2019 Randomized, double-blind, within-subjects crossover n = 14

Citations in the library

Cited by 16

and 11 more in the library

Cites 20

and 15 more in the library

Explore topics